Top Markets
#1 Black Phoenix Black Phoenix +860.13%
#2 QuantixAI QuantixAI +102.33%
#3 Pons Pons +27.37%
#4 MetaDAO MetaDAO +26.91%
#5 LayerZero LayerZero +21.44%
#6 Bedrock Bedrock +19.47%
#7 Ontology Gas Ontology Gas +19.36%
#8 SPX6900 SPX6900 +15.81%
#9 peaq peaq +14.71%
#10 Prom Prom +14.40%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Avidity Biosciences Inc Avidity Biosciences Inc

Avidity Biosciences Inc

RNAM
Rang in Aktien #2183
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Aktienkurs
$71.34
Zuletzt synchronisiert: 2026-03-03
Marktkapitalisierung
$9.84B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-
Land
US
Handel Avidity Biosciences Inc (RNAM)

Kategorie

Healthcare
EPS für Avidity Biosciences Inc (RNAM)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Avidity Biosciences Inc beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Avidity Biosciences Inc von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH